Bio Vitos Pharma AB (publ)

OM:BIOVIT Stock Report

Market Cap: SEK 26.4m

Bio Vitos Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BIOVIT?
Owner TypeNumber of SharesOwnership Percentage
Institutions760,0771.93%
Public Companies2,798,3447.1%
Individual Insiders3,825,1719.71%
General Public15,753,07740%
Private Companies16,265,42541.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1046.5%.

Top Shareholders

Top 16 shareholders own 60.02% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.7%
Andra Februari AB
7,762,557SEK 5.2m0%no data
16.1%
BIO Vitos Norge AS
6,351,732SEK 4.3m0%no data
7.1%
Double Bond Pharmaceutical International AB (publ)
2,798,344SEK 1.9m0%no data
6.33%
Ann Carnefeldt Crogh
2,492,405SEK 1.7m0%no data
2.54%
Norvolt As
1,000,000SEK 670.0k0%no data
2.09%
StrÖMsnÄS HerrgÅRd Ab
824,491SEK 552.4k0%no data
2.08%
Morten Skjonberg
819,902SEK 549.3k0%no data
1.93%
UBS Asset Management AG
760,002SEK 509.2k0%no data
0.83%
Stockholm Karlstad Invest Ab
326,645SEK 218.9k0%no data
0.75%
Jesper Birgemo
294,021SEK 197.0k0%no data
0.24%
Hjalmar Didrikson
96,168SEK 64.4k0%no data
0.23%
Mathias Karlsson
88,805SEK 59.5k0%no data
0.052%
Anna Dalgaard
20,410SEK 13.7k0%no data
0.023%
Joen Averstad
9,155SEK 6.1k160%no data
0.011%
Karin Dahllof
4,305SEK 2.9k0%no data
0.00019%
FCG Fonder AB
75SEK 50.20%no data